Human Epidermal Growth Factor Receptor 2 (HER2) –Specific Chimeric Antigen Receptor–Modified T Cells for the Immunotherapy of HER2-Positive Sarcoma
2015 · Journal of Clinical Oncology · 959 citations
https://doi.org/10.1200/jco.2014.58.0225
J
John Hicks
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
516
Papers
21.6K
Citations
73
h-index
297
i10-index
John Hicks is an academic researcher from Baylor College of Medicine. The author has contributed to research in topics: CAR-T cell therapy research & Sarcoma Diagnosis and Treatment & Dental Erosion and Treatment. The author has an h-index of 73, co-authored 439 publications.
ORCID: 0000-0002-1464-3803Papers by this author
worksCOPA mutations impair ER-Golgi transport and cause hereditary autoimmune-mediated lung disease and arthritis
2015 · Nature Genetics · 389 citations
https://doi.org/10.1038/ng.3279
Tumor response and endogenous immune reactivity after administration of HER2 CAR T cells in a child with metastatic rhabdomyosarcoma
2020 · Nature Communications · 161 citations
https://doi.org/10.1038/s41467-020-17175-8
State of the art review in gonadal dysgenesis: challenges in diagnosis and management
2014 · International Journal of Pediatric Endocrinology · 153 citations
https://doi.org/10.1186/1687-9856-2014-4
Immunotherapy targeting HER2 with genetically modified T cells eliminates tumor-initiating cells in osteosarcoma
2011 · Cancer Gene Therapy · 117 citations
https://doi.org/10.1038/cgt.2011.83
Intercellular adhesion molecule-1 deficiency protects MRL/MpJ-Fas(lpr) mice from early lethality
1997 · The Journal of Immunology · 96 citations
https://doi.org/10.4049/jimmunol.159.4.2058
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat